JPS62148485A - 新規の４−モルホリニル−１ｈ−インド−ル誘導体及びそれらの塩、それらの製造方法、それらの製造用中間体、それらの医薬としての使用並びにそれらを含有する組成物 - Google Patents

新規の４−モルホリニル−１ｈ−インド−ル誘導体及びそれらの塩、それらの製造方法、それらの製造用中間体、それらの医薬としての使用並びにそれらを含有する組成物

Info

Publication number
JPS62148485A
JPS62148485A JP61295113A JP29511386A JPS62148485A JP S62148485 A JPS62148485 A JP S62148485A JP 61295113 A JP61295113 A JP 61295113A JP 29511386 A JP29511386 A JP 29511386A JP S62148485 A JPS62148485 A JP S62148485A
Authority
JP
Japan
Prior art keywords
formula
compound
morpholinyl
following formula
tables
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61295113A
Other languages
English (en)
Japanese (ja)
Inventor
ジヤンクロード・ガスク
リユシアン・ネデレツク
クロード・レツテイアン
ダイナ・ワイスマン・ナノプーロス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of JPS62148485A publication Critical patent/JPS62148485A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP61295113A 1985-12-13 1986-12-12 新規の４−モルホリニル−１ｈ−インド−ル誘導体及びそれらの塩、それらの製造方法、それらの製造用中間体、それらの医薬としての使用並びにそれらを含有する組成物 Pending JPS62148485A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8518482 1985-12-13
FR8518482A FR2591595B1 (fr) 1985-12-13 1985-12-13 Nouveaux derives du 4-morpholinyl 1h-indole, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant, et intermediaires

Publications (1)

Publication Number Publication Date
JPS62148485A true JPS62148485A (ja) 1987-07-02

Family

ID=9325757

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61295113A Pending JPS62148485A (ja) 1985-12-13 1986-12-12 新規の４−モルホリニル−１ｈ−インド−ル誘導体及びそれらの塩、それらの製造方法、それらの製造用中間体、それらの医薬としての使用並びにそれらを含有する組成物

Country Status (11)

Country Link
US (2) US4699907A (https=)
EP (1) EP0230179B1 (https=)
JP (1) JPS62148485A (https=)
AT (1) ATE81127T1 (https=)
CA (1) CA1266471A (https=)
DE (1) DE3686876T2 (https=)
ES (1) ES2043605T3 (https=)
FR (1) FR2591595B1 (https=)
GR (1) GR3006137T3 (https=)
HU (1) HU199458B (https=)
PT (1) PT83920B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69114210T2 (de) * 1990-08-13 1996-05-02 Hoechst Roussel Pharma Carbamoyl-1-(pyridinylalkyl)-1H-indole, -indoline und verwandte Verbindungen.
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
FR2792313A1 (fr) * 1999-04-13 2000-10-20 Synthelabo Derives de 2-aminoethyl-indole, leur preparation et leur application en therapeutique
US7229986B2 (en) 2000-05-16 2007-06-12 Takeda Pharmaceutical Company Ltd. Melanin-concentrating hormone antagonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2512817A1 (fr) * 1981-09-17 1983-03-18 Roussel Uclaf Nouveaux derives de l'aminomethyl 1h-indole-4-methanol et leurs sels, leur procede de preparation, leur application a titre de medicaments, les compositions les renfermant et leurs intermediaires de preparation
FR2501208A1 (fr) * 1981-09-17 1982-09-10 Roussel Uclaf Nouveaux derives du morpholinyl-indole, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et composition les renfermant

Also Published As

Publication number Publication date
EP0230179A3 (en) 1988-05-18
FR2591595B1 (fr) 1988-09-09
US4699907A (en) 1987-10-13
ES2043605T3 (es) 1994-01-01
PT83920A (fr) 1987-01-01
EP0230179A2 (fr) 1987-07-29
HU199458B (en) 1990-02-28
EP0230179B1 (fr) 1992-09-30
DE3686876T2 (de) 1993-05-06
PT83920B (pt) 1989-06-30
DE3686876D1 (de) 1992-11-05
ATE81127T1 (de) 1992-10-15
FR2591595A1 (fr) 1987-06-19
CA1266471A (fr) 1990-03-06
US4736042A (en) 1988-04-05
GR3006137T3 (https=) 1993-06-21
HUT45996A (en) 1988-09-28

Similar Documents

Publication Publication Date Title
CN107074829B (zh) 用于抑制微粒体前列腺素e2合成酶-1的新型甲基-哌啶化合物
DE68913487T2 (de) Piperazine-Derivate.
DE69934238T2 (de) Azabicyclo-verbindungen welche die inhibition der zell adhesion modulieren
DE69835688T2 (de) Substituierte anilide
JP7846113B2 (ja) 置換ピペリジノ化合物及び関連する治療方法
CN110719902A (zh) Ssao抑制剂
CN114375193B (zh) 甲状腺激素受体β激动剂化合物
EP0708101A1 (fr) Nouveaux dérivés de pipéridine utiles comme antagonistes des récepteurs des neurokinines
JP2002514644A (ja) メタロプロテイナーゼ阻害剤としての置換アリールヒドロキサム酸
JPS61236764A (ja) 新規なインドール誘導体およびその酸付加塩ならびにそれらを含有する精神病治療剤
AU2017251555B2 (en) Pyridone derivative comprising heteroatomic ring butane substituent, for treating fibrosis and inflammatory diseases
EP0239445A2 (fr) Dérivés du 1,2,5,6-tétrahydropyridin-3-carboxaldéhyde oxime, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant
PT1720544E (pt) Novos derivados azabicíclios, o processo para a sua preparação, e os compostos farmacêuticos que os contenham
JP2002514647A (ja) メタロプロテイナーゼ阻害薬としての新規な置換アリールヒドロキサム酸
NZ243337A (en) 1-piperidyl substituted quinoline derivatives and pharmaceutical compositions
JPH06506956A (ja) ピリドンの新規な誘導体、それらの製造法、得られる新規な中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物
FR2567884A1 (fr) Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
JPS62148485A (ja) 新規の４−モルホリニル−１ｈ−インド−ル誘導体及びそれらの塩、それらの製造方法、それらの製造用中間体、それらの医薬としての使用並びにそれらを含有する組成物
PT96154B (pt) Processo para a preparacao de derivados de carbamoilo e de composicoes farmaceuticas que os contem
DE69937603T2 (de) Dihydro-benzo(1,4)oxazine und tetrahydro-quinoxaline
FR2460947A1 (fr) Nouveau derives n-substitues du tetrahydropyridinyl-indole, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
JPH04257579A (ja) ４−（２−フェニルエチル）ピペリジン−１−イル基をもつエタノールおよびエタノン誘導体、その製造および治療的応用
CA1139763A (fr) Procede d'obtention de nouveaux aryltrifluoroethanols
CN101362725A (zh) 川芎嗪胍类衍生物的制备方法及其应用
WO2023061492A1 (zh) 2-氧代-3-氮杂双环[3.1.0]己烷衍生物